News

At 5 years, CARB-X celebrates progress on antibiotic development

At 5 years, CARB-X celebrates progress on antibiotic development

CIDRAP | In this interview between CARB-X Executive Director Kevin Outterson and reporter Chris Dall of CIDRAP, University of Minnesota’s Center for Infectious Disease Research and Policy, Outterson talks stellar science and changes across the broader AMR landscape during CARB-X’s first five years as well as future collaborations necessary to see the successful launch of products and fund antibiotic research more sustainably.

Full Story